Web Content
'Transformative' pancreatic cancer drug doubles survival time | New Scientist
People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions
TypeArticle
Domainwww.newscientist.com
Providernews
Recommend it?





